Headquartered in Indianapolis, Indiana, Eli Lilly and Company (LLY) researches, develops, and markets medicines across cardiometabolic disease, oncology, immunology, neuroscience, and beyond. With a ...

Research and development (R&D) are essential elements of Eli Lilly’s operations, enabling the company to remain at the forefront of pharmaceutical innovation. In broader equity narratives referencing ...

Eli Lilly (LLY) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the ...

Shares of Eli Lilly & Co. LLY slid 1.28% to $1,028.83 Wednesday, on what proved to be an all-around great trading session for ...

Eli Lilly and Company (NYSE:LLY) shares are up on Monday as the company benefits from positive market sentiment following ...

Shares of Eli Lilly & Co. LLY slid 1.34% to $1,009.52 Friday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index SPX rising 0.69% to 6,909.51 and ...

Eli Lilly and Company (NYSE:LLY) is included in the list of the best performing S&P 500 stocks in the last five years. As of February 6, 2026, robust demand for the company’s obesity and diabetes ...

On Tuesday, we'll get the latest from names including Pfizer, Pepsi, Merck, Advanced Micro Devices, and Chipotle . While ...